Pelvic Floor Study: Biomechanical Properties of the Female Pelvic Floor
1 other identifier
observational
40
1 country
1
Brief Summary
Pelvic floor dysfunction in the form of pelvic organ prolapse or urinary and fecal incontinence is a sequela for some women who experience injuries during birth. It affects adult women of all ages. The life time risk for women by age of 80 years for undergoing surgical correction is shown to be 11.1 % , and 29 % of them will undergo re-operation for recurrences later on. Still, even today the biomechanics of the pelvic floor is not understood enough. The aim of our study is to investigate the biomechanical properties of the female pelvic floor, i.e. the vaginal wall, by means of clinical, sonomorphometric (ultrasound), histological and elastomechanical examinations. In principle, the elasto-mechanical properties of the vaginal wall will be examined by the new and innovative so called aspiration device, developed at the Eidgenoessische Technische Hochschule (ETH) Zurich, Switzerland. This tool generates a low-pressure of -25 mbar at the vaginal wall, aspirating it under visual control by aid of an integrated video camera and therefore allowing to measure the difference of its convexity under aspiration and at rest. In case of prolapse surgery, this allows us to take a biopsy of the measured vaginal wall and analyze it at the Institute of Anatomy at the University of Zurich-Irchel by means of histological (e.g. connective tissue, extracellular matrix) and molecular biological examination. With an increasing elderly population, more and more women will need surgery for pelvic organ prolapse. While effective in restoring anatomy, sometimes by aid of meshes made out of polypropylene, the functional outcomes and quality of life are not always restored satisfactorily. This interdisciplinary project intends to add a contribution to this for our patient still bothersome situation and to help to detect risk factors for developing pelvic floor dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 4, 2010
CompletedFirst Posted
Study publicly available on registry
January 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedNovember 6, 2020
November 1, 2020
5.4 years
January 4, 2010
November 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
normative values for the aspiration technique
one year
correlation of elasticity parameters with histology
one year
Study Arms (2)
control group
female patients without pelvic organ prolapse, stage 0 or I (POP-Q)
pelvic organ prolapse
female patients with pelvic organ prolapse stage II or higher (POP-Q)
Eligibility Criteria
female patients who are referred to our university hospital
You may qualify if:
- pre- and postmenopausal women
- with pelvic organ prolapse, i.e. cysto- or rectocele, uterine descensus
- postmenopausal women
You may not qualify if:
- age under 18 years
- pregnancy / lactation
- current gynaecologic malignancies
- current malignancies of the pelvic floor
- infections such as HPV
- treatment with steroids or methotrexate
- no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- David Scheinerlead
- ETH Zurich (Switzerland)collaborator
- University of Zurichcollaborator
Study Sites (1)
University Hospital of Zurich, Clinic for Gynaecology
Zurich, 8091, Switzerland
Biospecimen
tissue (vaginal wall, urogenital diaphragm), whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David A Scheiner, MD
University Hospital of Zurich, Clinic for Gynaecology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Oberarzt
Study Record Dates
First Submitted
January 4, 2010
First Posted
January 5, 2010
Study Start
January 1, 2010
Primary Completion
June 1, 2015
Study Completion
December 1, 2021
Last Updated
November 6, 2020
Record last verified: 2020-11